Incyte Newsroom

J.P. Morgan Maintains Incyte(INCY.US) With Hold Rating, Announces Target Price $68

Moomoo NewsApr 21 19:31 ET

Incyte Is Maintained at Neutral by JP Morgan

Dow JonesApr 21 13:25 ET

Incyte Analyst Ratings

BenzingaApr 21 13:15 ET

JPMorgan Adjusts Incyte Price Target to $68 From $70, Maintains Neutral Rating

MT NewswiresApr 21 08:03 ET

BofA Securities Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $87

Moomoo NewsApr 20 19:31 ET

BofA Securities Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $87

Moomoo NewsApr 17 19:33 ET

BofA Adjusts Price Target on Incyte to $87 From $86, Keeps Buy Rating

MT NewswiresApr 17 11:13 ET

UBS Maintains Incyte(INCY.US) With Hold Rating, Cuts Target Price to $61

Moomoo NewsApr 9 19:33 ET

J.P. Morgan Maintains Incyte(INCY.US) With Hold Rating

Moomoo NewsApr 7 19:32 ET

J.P. Morgan Sticks to Their Hold Rating for Incyte (INCY)

TipRanksApr 7 07:03 ET

RBC Capital Maintains Incyte(INCY.US) With Hold Rating, Cuts Target Price to $64

Moomoo NewsApr 3 18:31 ET

RBC Lowers Price Target on Incyte to $64 From $68, Keeps Sector Perform Rating

MT NewswiresApr 3 07:25 ET

Leerink Partners Maintains Incyte(INCY.US) With Buy Rating, Cuts Target Price to $92

Moomoo NewsMar 25 01:32 ET

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX), Eli Lilly & Co (LLY) and Incyte (INCY)

TipRanksMar 24 20:46 ET

Incyte Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesMar 24 07:57 ET

Incyte Analyst Ratings

BenzingaMar 24 07:48 ET

Morgan Stanley Maintains Incyte(INCY.US) With Hold Rating, Cuts Target Price to $65

Moomoo NewsMar 24 06:31 ET

Incyte's Hold Rating: Balancing Pipeline Challenges and Established Product Valuation

TipRanksMar 24 06:02 ET

William Blair Maintains Incyte(INCY.US) With Hold Rating

Moomoo NewsMar 22 19:32 ET

Incyte (INCY) Was Downgraded to a Hold Rating at William Blair

TipRanksMar 22 10:59 ET